R-wave detection method for implantable cardioverter defibrillators
Perttu, J.S.; Brumwell, D.A.; Brewer, J.E.; Adams, T.P.
Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 1898
1998
ISSN/ISBN: 0098-1133 Accession: 033066217
PDF emailed within 1 workday: $29.90
Related References
Radbill, A.E.; Triedman, J.K.; Berul, C.I.; Fynn-Thompson, F.; Atallah, J.; Alexander, M.E.; Walsh, E.P.; Cecchin, F. 2010: System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients Heart Rhythm 7(2): 193-198Masoudi, F.A.; Go, A.S.; Magid, D.J.; Cassidy-Bushrow, A.E.; Doris, J.M.; Fiocchi, F.; Garcia-Montilla, R.; Glenn, K.A.; Goldberg, R.J.; Gupta, N.; Gurwitz, J.H.; Hammill, S.C.; Hayes, J.J.; Jackson, N.; Kadish, A.; Lauer, M.; Miller, A.W.; Multerer, D.; Peterson, P.N.; Reifler, L.M.; Reynolds, K.; Saczynski, J.S.; Schuger, C.; Sharma, P.P.; Smith, D.H.; Suits, M.; Sung, S.Hee.; Varosy, P.D.; Vidaillet, H.J.; Greenlee, R.T. 2012: Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice Circulation. Cardiovascular Quality and Outcomes 5(6): E78-E85
Zeitler, E.P.; Sanders, G.D.; Singh, K.; Greenfield, R.Ann.; Gillis, A.M.; Wilkoff, B.L.; Piccini, J.P.; Al-Khatib, S.M. 2018: Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 20(10): 1621-1629
Cheng, A.; Zhang, Y.; Blasco-Colmenares, E.; Dalal, D.; Butcher, B.; Norgard, S.; Eldadah, Z.; Ellenbogen, K.A.; Dickfeld, T.; Spragg, D.D.; Marine, J.E.; Guallar, E.; Tomaselli, G.F. 2014: Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD) Circulation. Arrhythmia and Electrophysiology 7(6): 1084-1091
Peterson, P.N.; Greenlee, R.T.; Go, A.S.; Magid, D.J.; Cassidy-Bushrow, A.; Garcia-Montilla, R.; Glenn, K.A.; Gurwitz, J.H.; Hammill, S.C.; Hayes, J.; Kadish, A.; Reynolds, K.; Sharma, P.; Smith, D.H.; Varosy, P.D.; Vidaillet, H.; Zeng, C.X.; Normand, S-Lise.T.; Masoudi, F.A. 2017: Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators Journal of the American Heart Association 6(11)
Deisenhofer, I.; Kolb, C.; Schreieck, J.; Karch, M.R.; Zrenner, B.; Schmitt, C. 2000: Possible benefits of dual-chamber implantable cardioverter-defibrillators in reducing inadequate therapy compared to conventional single-chamber implantable cardioverter-defibrillators A clinical randomised study European Heart Journal 21(Abstract Suppl): 470
Deisenhofer, I.; Kolb, C.; Schreieck, J. 2000: Do new dual-chamber implantable cardioverter-defibrillators reduce the incidence of inadequate therapy compared to conventional single-chamber implantable cardioverter-defibrillators? A clinical randomised study Circulation 102(18): 2; 397
Sweeney, M.O.; Shea, J.B.; Ellison, K.E. 2002: Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: indications, surgical approach, and long-term clinical results Pacing and Clinical Electrophysiology: Pace 25(12): 1715-1723
Stroobandt, R.X. 2002: Morphology discrimination of ventricular tachycardia from supraventricular tachycardia by implantable cardioverter defibrillators: are implantable cardioverter defibrillators really starting to look at arrhythmias with the eyes of a cardiologist? Journal of Cardiovascular Electrophysiology 13(5): 442-443
Hsu, S.S.; Mohib, S.; Schroeder, A.; Deger, F.T. 2004: T wave oversensing in implantable cardioverter defibrillators Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 11(1): 67-72
Shih, H.T.; Wyse, D.G.; Rizo-Patron, C.; Stamato, N.J.; Daubert, J.P.; Lancaster, S.; Renfroe, E.G.; Connors, N.; Pacifico, A.; Crevey, B.; Jennings, C.; Whiting, D.; Yao, Q. 1998: Regional differences in utilization of implantable cardioverter/defibrillators - an Antiarrhythmics Versus Implantable Defibrillators (Avl D) registry study Journal of the American College of Cardiology 31(Supp S2): 435
Shih, H.T.; Wyse, D.G.; Rizo Patron, C.; Stamato, N.J.; Daubert, J.P.; Lancaster, S.; Renfroe, E.G.; Connors, N.; Pacifico, A.; Crevey, B.; Jennings, C.; Whiting, D.; Yao, Q. 1998: Regional differences in utilization of implantable cardioverter/defibrillators An antiarrhythmics versus implantable defibrillators registry study Journal of the American College of Cardiology 31(2 Suppl A): 435A
Tullo, N.G.; Stamato, N.J.; Reiter, M.; Reiffel, J.; Goldner, B.; Bigger, J.T.; Rosenberg, Y.; Whiting, D.; Graham Renfroe, E.; Ledingham, R.B.; Hallstrom, A.; Avid Investigators 1999: Prior antiarrhythmic drug use does not predict survival but does affect impact of implantable cardioverter-defibrillators Analysis of the antiarrhythmics versus implantable defibrillators study Circulation 100(18): 1; 570
Day, J.D.; Doshi, R.N.; Belott, P.; Birgersdotter-Green, U.; Behboodikhah, M.; Ott, P.; Glatter, K.A.; Tobias, S.; Frumin, H.; Lee, B.K.; Merillat, J.; Wiener, I.; Wang, S.; Grogin, H.; Chun, S.; Patrawalla, R.; Crandall, B.; Osborn, J.S.; Weiss, J.Peter.; Lappe, D.L.; Neuman, S. 2007: Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations) Circulation 115(18): 2382-2389
Olshansky, B.; Atteya, G.; Cannom, D.; Heidbuchel, H.; Saarel, E.V.; Anfinsen, O-Gunnar.; Cheng, A.; Gold, M.R.; Müssigbrodt, A.; Patton, K.K.; Saxon, L.A.; Wilkoff, B.L.; Willems, R.; Dziura, J.; Li, F.; Brandt, C.; Simone, L.; Wilhelm, M.; Lampert, R. 2019: Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry Heart Rhythm 16(4): 581-587
Gottlieb, C.; Callans, D.J.; Marchlinski, F. 1998: Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results Pacing and Clinical Electrophysiology: Pace 21(11 Part 1): 2016-2020
Gao, L.; Lu, C.-y.; Wang, S.-w.; Xue, Q.; Yan, W.; Zhou, S.-h.; Chen, R.; Liu, P.; Zhai, J.-y. 2010: T-wave oversensing and inappropriate shocks in implantable cardioverter defibrillators Chinese Medical Journal 123(9): 1222-1224
Wilson, D.G.; Leventigiannis, G.; Barr, C.; Morgan, J.M. 2016: ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators International Journal of Cardiology 220: 27-31
Gleva, M.J.; Wang, Y.; Curtis, J.P.; Berul, C.I.; Huddleston, C.B.; Poole, J.E. 2017: Complications Associated with Implantable Cardioverter Defibrillators in Adults with Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry) American Journal of Cardiology 120(10): 1891-1898
Jenkins, J.M.; Caswell, S.A. 1996: Detection algorithms in implantable cardioverter defibrillators Proceedings of the IEEE 84(3): 428-445